The molecular phenotype of heparan sulfate in the Hs2st-/- mutant mouse.
dc.contributor.author | Merry, Catherine L R | |
dc.contributor.author | Bullock, Simon L | |
dc.contributor.author | Swan, Daniel C | |
dc.contributor.author | Backen, Alison C | |
dc.contributor.author | Lyon, Malcolm | |
dc.contributor.author | Beddington, Rosa S | |
dc.contributor.author | Wilson, Valerie A | |
dc.contributor.author | Gallagher, John T | |
dc.date.accessioned | 2009-11-10T10:06:22Z | |
dc.date.available | 2009-11-10T10:06:22Z | |
dc.date.issued | 2001-09-21 | |
dc.identifier.citation | The molecular phenotype of heparan sulfate in the Hs2st-/- mutant mouse. 2001, 276 (38):35429-34 J. Biol. Chem. | en |
dc.identifier.issn | 0021-9258 | |
dc.identifier.pmid | 11457822 | |
dc.identifier.doi | 10.1074/jbc.M100379200 | |
dc.identifier.uri | http://hdl.handle.net/10541/85732 | |
dc.description.abstract | Heparan sulfate (HS) is a co-receptor for a number of growth factors, morphogens, and adhesion proteins. HS biosynthetic modifications may determine the strength and outcome of HS-ligand interactions. We previously described the phenotype of mice with a gene-trap mutation in Hs2st, encoding the key HS 2-O-sulfotransferase enzyme in HS polymer modification. In contrast to the early developmental failure of embryos lacking HS, the onset of abnormalities in the Hs2st(-/-) mice occurs only after midgestation, the most dramatic being the complete failure of kidney development. Uronate 2-O-sulfates were not detected in the mutant HS, indicating a complete loss of function of Hs2st. However, the domain structure of the mutant HS is conserved, and compensatory increases in N- and 6-O-sulfation maintain the overall charge density. The apparent affinities of the mutant HS for hepatocyte growth factor/scatter factor and fibronectin were unchanged but were reduced for fibroblast growth factor-1 and -2. Surprisingly, the Hs2st(-/-) cells were able to mount an apparently normal signaling response to fibroblast growth factor-1 and -2 as well as to hepatocyte growth factor/scatter factor. | |
dc.language.iso | en | en |
dc.subject.mesh | Animals | |
dc.subject.mesh | Disaccharides | |
dc.subject.mesh | Fibroblast Growth Factors | |
dc.subject.mesh | Heparitin Sulfate | |
dc.subject.mesh | Hepatocyte Growth Factor | |
dc.subject.mesh | Hydrolysis | |
dc.subject.mesh | Mice | |
dc.subject.mesh | Mice, Mutant Strains | |
dc.subject.mesh | Nitrous Acid | |
dc.subject.mesh | Phenotype | |
dc.subject.mesh | Polysaccharide-Lyases | |
dc.subject.mesh | Sulfotransferases | |
dc.title | The molecular phenotype of heparan sulfate in the Hs2st-/- mutant mouse. | en |
dc.type | Article | en |
dc.contributor.department | Cancer Research Campaign Department of Medical Oncology, Christie Hospital NHS Trust, Manchester M20 4BX, United Kingdom. cmerry@picr.man.ac.uk | en |
dc.identifier.journal | The Journal of Biological Chemistry | en |
html.description.abstract | Heparan sulfate (HS) is a co-receptor for a number of growth factors, morphogens, and adhesion proteins. HS biosynthetic modifications may determine the strength and outcome of HS-ligand interactions. We previously described the phenotype of mice with a gene-trap mutation in Hs2st, encoding the key HS 2-O-sulfotransferase enzyme in HS polymer modification. In contrast to the early developmental failure of embryos lacking HS, the onset of abnormalities in the Hs2st(-/-) mice occurs only after midgestation, the most dramatic being the complete failure of kidney development. Uronate 2-O-sulfates were not detected in the mutant HS, indicating a complete loss of function of Hs2st. However, the domain structure of the mutant HS is conserved, and compensatory increases in N- and 6-O-sulfation maintain the overall charge density. The apparent affinities of the mutant HS for hepatocyte growth factor/scatter factor and fibronectin were unchanged but were reduced for fibroblast growth factor-1 and -2. Surprisingly, the Hs2st(-/-) cells were able to mount an apparently normal signaling response to fibroblast growth factor-1 and -2 as well as to hepatocyte growth factor/scatter factor. |